Aptamers as targeted therapeutics: current potential and challenges
Nature Reviews Drug Discovery 16, 440 (2017).
doi:10.1038/nrd.2017.86
Author: Jiehua Zhou & John Rossi
Nature Reviews Drug Discovery16, 181–202 (2017)Base Pair Biotechnologies and Apterna were omitted from Table 3 in this article. These have now been included.
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Jiehua Zhou John Rossi Tags: Corrigendum Source Type: research
More News: Biotechnology | Drugs & Pharmacology